Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel poliglumex vs paclitaxel in women with advanced NSCLC and high estradiol
NCT00551733Phase 3Terminated
- Sponsor
- CTI BioPharma Corp.
- Start
- Aug 2007
- Primary completion
- Dec 2007
- Countries
- 1
01
Overview
A Phase 3 trial of paclitaxel poliglumex in non-small cell lung cancer (NSCLC), sponsored by CTI BioPharma Corp.. Started Aug 2007; status: terminated.
02
Drugs
paclitaxel poliglumex
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00551733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551733.